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FrpB (for Fe-regulated protein B) is a 76-kDa outer membrane protein that is part of the iron regulon of
Neisseria gonorrhoeae and Neisseria meningitidis. The frpB gene from gonococcal strain FA19 was cloned and
sequenced. FrpB was homologous to several TonB-dependent outer membrane receptors of Escherichia coli as
well as HemR of Yersinia enterocolitica and CopB of Moraxella catarrhalis. An V insertion into the frpB coding
sequence caused a 60% reduction in 55Fe uptake from heme, but careful analysis suggested that this effect was
nonspecific. While FrpB was related to the family of TonB-dependent proteins, a function in iron uptake could
not be documented.
Many factors contribute to the virulence of bacterial patho-
gens. The ability to adhere to and/or invade eukaryotic cells
(20), the secretion of toxins-hemolysins (20), the synthesis of
capsule (12, 28) and immunoglobulin proteases (20), the sia-
lylation of surface components (52), phase and antigenic vari-
ation (37), and the ability to scavenge iron or other essential
nutrients from host sources (65) are all associated with viru-
lence. While many factors work in concert to establish infec-
tion, the abilities to adhere and to obtain iron may be the only
factors common to all pathogenic bacteria.
Iron is essential for many biological processes. Besides elec-
tron transport, iron serves at the catalytic center for enzymes
involved in the reduction of dinitrogen and ribonucleotides, as
well as those involved in the activation and decomposition of
peroxides (4). The concentration of free iron in mammalian
tissue (10218 M) is far below that required to support bacterial
growth (0.4 to 4 mM) (64), and therefore, pathogens have
evolved multiple, coordinately expressed mechanisms to scav-
enge iron from host iron storage and transport compounds.
Most bacteria synthesize and secrete high-affinity, low-molec-
ular-weight, iron-chelating compounds called siderophores
(39). These compounds are capable of stripping iron from the
host glycoproteins transferrin (Tf) and lactoferrin (Lf) (10),
and the cell surface of iron-releasing tissues, i.e., macrophages
and hepatocytes (11). The ferri-siderophore complex is then
bound by a specific receptor on the bacterial cell surface and
internalized by an energy-requiring process.
Neisseria gonorrhoeae does not synthesize siderophores (66).
Nevertheless, it has been reported to utilize the Escherichia
coli siderophores aerobactin (67) and enterobactin (45). All
gonococci are capable of utilizing Tf-bound iron directly (38).
A saturable specific gonococcal Tf receptor is responsible for
this activity (9). The Tf receptor appears to be composed of
two iron-repressible Tf-binding proteins (50), designated Tbp1
and Tbp2 (21). Tbp1 is essential for utilization of Tf-bound
iron in vitro (13). Tbp2, although not essential in vitro, appears
to make the process of iron utilization from Tf more efficient
(2) and may be essential in vivo. Lf also serves as an iron source
for some strains of N. gonorrhoeae and requires direct contact
as well (36). Biswas and Sparling have recently isolated a gene
that encodes the 105-kDa iron-repressible, outer membrane,
Lf-binding protein (Lbp) from gonococcal strain FA19 (6).
Citrate, heme, hemoglobin, and hemoglobin bound to hapto-
globin but not heme bound to hemopexin or serum albumin
also serve as iron sources for gonococci in vitro (17, 38).
The iron uptake systems of Neisseria meningitidis are similar
to those described for N. gonorrhoeae (3, 17). Dyer et al. (16)
reported a 70-kDa iron-regulated major outer membrane pro-
tein common to N. gonorrhoeae and N. meningitidis. This pro-
tein has been designated FrpB (21). Previous studies showed
that FrpB is surface exposed and immunogenic in vivo (1, 16,
41). Polyclonal and some monoclonal anti-FrpB antibodies
recognize the denatured protein on Western blots (immuno-
blots) of nearly all gonococcal and meningococcal isolates
tested (reference 16 and this study). Other monoclonal anti-
bodies directed against meningococcal FrpB are bactericidal
and strain specific (41). Nevertheless, the size of FrpB appears
to be well conserved. Interest in the role of FrpB in iron uptake
was promoted by studies of an ethylmethanesulfonate-mu-
tagenized, streptonigrin-enriched, meningococcal mutant
(FAM11) that did not express FrpB (16). FAM11 was capable
of using heme and hemoglobin normally but was unable to use
ferric ions from a variety of sources including Tf and Lf. Nev-
ertheless, revertants that regained the ability to utilize Tf and
Lf never regained expression of FrpB. The inability to trans-
form the mutation into a clean genetic background prevented
clear interpretation of the role of FrpB in iron utilization.
In this paper, we report the cloning, sequencing, and mu-
tagenesis of frpB from gonococcal strain FA19 and discuss
experiments designed to determine the physiological function
of the FrpB protein.
MATERIALS AND METHODS
Strains and growth conditions. Bacterial strains used in this study are de-
scribed in Table 1. Neisseria strains were routinely cultured on gonococcal base
(GCB) medium (Difco Laboratories) containing Kellogg’s supplements I and II
(29) and grown overnight at 358C in an atmosphere of 5% CO2. Antibiotic
selection employed chloramphenicol at 1 mg/ml for mTn3(Cm) (51)-mu-
tagenized strains and streptomycin at 100 mg/ml for V (44)-mutagenized strains.
For Western blot analysis of total membrane proteins of iron-stressed gono-
cocci, cells were grown in chemically defined medium (CDM) as previously
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described (13). Cultures were made iron replete as indicated by the addition of
100 mM ferric citrate.
E. coli strains were routinely cultured on Luria-Bertani medium (47). Antibi-
otic selection was 100 mg of ampicillin per ml, 100 mg of streptomycin per ml, 40
mg of kanamycin per ml, and/or 30 mg of chloramphenicol per ml. d-Aminole-
vulinic acid was used at 30 mg/ml, and heme was used at 50 mg/ml. E. coli cultures
were iron stressed by the addition of 200 mM 2,2-dipyridyl (Sigma Chemical Co.,
St. Louis, Mo.). Deferoxamine mesylate (Desferal) was obtained from Ciba-
Geigy (Basel, Switzerland).
SDS-PAGE and Western blotting. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) was performed in a 7.5% polyacrylamide resolving
gel and a 4.5% polyacrylamide stacking gel. Electrophoresis was carried out at
either 40 mA for one gel or 80 mA for two gels in the discontinuous buffer system
of Laemmli (32). Transfer and development were as described previously (23,
61).
Preparation of polyclonal antisera and monoclonal antibodies. Preparation of
polyclonal antisera was described previously (8). Anti-FrpB monoclonal antibod-
ies were generated by methods described previously (60).
DNA isolation, digestion, and Southern blot analysis. Chromosomal DNA was
purified by CsCl-gradient centrifugation according to the method of Stern et al.
(54). Plasmids were purified either by CsCl centrifugation or according to the
instructions provided in the Magic Miniprep DNA Purification Kit (Promega,
Madison, Wis.). Southern blotting and DNA hybridizations were performed as
previously described (13). Restriction enzymes, Klenow fragment of DNA poly-
merase I, and T4 DNA ligase were purchased from New England Biolabs (Bev-
erly, Mass.) or Bethesda Research Laboratories (Gaithersburg, Md.) and were
used according to the manufacturer’s specifications. l-ZapII and pBluescript II
SK1 were obtained from Stratagene (La Jolla, Calif.).
DNA sequencing and sequence analysis. CsCl-purified pUNCH319 and
pUNCH325 were used as templates for double-stranded DNA sequencing (31)
with United States Biochemical Sequenase and the dideoxy chain termination
procedure of Sanger et al. (48). Both dG- and dI-labeling reactions were carried
out for all primers. Both strands of pUNCH319 were sequenced with vector-
specific or insert-specific primers. Exonuclease III-exonuclease VII nested dele-
tions (40) were generated from the MluI end of pUNCH325, and vector-specific
primers were used to sequence individual deletion clones. Internal primers were
used to sequence gaps between clones as well as the opposite strand. DNA
sequences were analyzed with the Genetics Computer Group software package
(15) (University of Wisconsin).
Mutagenesis and gonococcal transformation. pHP45V (44) was used to inser-
tionally inactivate frpB. pUNCH321 was digested with BglI, and ends were
repaired with Klenow fragment. pHP45V was digested with SmaI, and the 2.0-kb
V fragment was isolated from an agarose gel according to the instructions
provided in the Geneclean II Kit (Bio 101 Inc., La Jolla, Calif.). Transformation
of plasmid DNA into FA19 was as previously described (7).
Preparation of FrpB for amino-terminal sequence analysis. N-Lauroylsar-
cosine (Sigma)-insoluble membrane fractions were prepared from iron-stressed
gonococcal strain UU1008, and protein concentration was determined by a
bicinchoninic acid assay (Pierce, Rockford, Ill.). Two hundred micrograms of
protein was loaded into a preparative well of an SDS–7.5% polyacrylamide gel,
poured 24 h previously to permit TEMED (N,N,N9,N9-tetramethylethylenedia-
mine) and ammonium persulfate to evaporate. Electrophoresis was carried out
at 40 mA of constant current with the discontinuous buffer system of Laemmli
(32). The gel was soaked for 15 min in transfer buffer (13) before transferring.
Polyvinylidene difluoride membrane was placed in 100% methanol for 2 s,
transferred to distilled deionized water for 5 min, and soaked in transfer buffer
for 10 min prior to transfer. Transfer was for 3.5 h at 90 mA in a submerged
trans-blot apparatus (Bio-Rad, Richmond, Calif.). Subsequent to transfer, the
polyvinylidene difluoride membrane was stained for 5 min in 0.1% Coomassie
brilliant blue–20% methanol–10% acetic acid to visualize proteins and destained
for 10 min in distilled deionized H2O with one change. Filtrate was frozen at
2208C overnight. FrpB was identified by molecular weight, and the amino-
terminal amino acid sequence of the protein on the filter was determined by the
Protein Microsequencing Facility at University of California, Los Angeles.
55Fe uptake assays. Data were compiled from three individual experiments
performed in triplicate on separate days. Gonococci were iron stressed as pre-
viously reported (2) prior to experimentation. SDS-PAGE and Western blotting
of whole-cell lysates were routinely performed to determine that cultures were
consistently and equivalently iron stressed, as evidenced by reactivity with anti-
FrpB monoclonal antibody and/or anti-Tbp1 antisera. Iron uptake assays were
performed as previously reported (9) with the following modifications. Filters
were blocked just prior to experimentation with 30 ml of 10-mg/ml bovine serum
albumin in 13 CDM. Assays were performed in 200-ml volumes in 96-well
filtration plates (MAHV; Millipore, Bedford, Mass.) at 358C in a 5% CO2
TABLE 1. Bacterial strains, plasmids, and phage
Strain, plasmid,
or phage Description Reference or source
Strains
FA19 Wild type 38,
FA6807 frpB::V (FrpB2) This study
FA6808 frpB::V tbpA::mTn3(Cm) (FrpB2 Tbp12) This study
FA6747 tbpA::mTn3(Cm) (Tbp12) 13
FA6819 DtbpB (Tbp22) 2
FA6775 lbpA::mTn3(Cm) (Lpb2) 6
UU1008 Wild type Zell McGee
DH5aMCR F2 mcrA mcrB mrr f80dlacZDM15 D(argF-lac)U169 recA1 endA1 hsdR
hsdM supE44 l2 thi-1 gyrA96 relA1
Bethesda Research Laboratories
BN1071 F2 pro trp rslL entA (Ent2 FepA1) 30
AN102 BN1071 leu fepA (Ent1 FepA2) 30
KDF541 BN1071 entA fepA (Ent2 FepA2) 46
KDF541/pABN6 (Ent2 FepA2 IutA1 Iuc2) 14
LG1315/pcolV BN1071 cir (IutA1 Iuc1) 63
RK1065 hemA R. Kadner
HB101 F2 hsd20 (rB mB
2) recA13 ara-14 proA2 lacY1 galK2 rpsL20 (Smr) xyl-5
mtl-1 supE44 l2
47
C386 ompA lpp 53
Plasmids and phage
pACYC184 ori p15a Cmr Tcr New England Biolabs
pBluescript II SK1 ori pMB1 Apr Stratagene
pHP45V Source for the V fragment (Smr) 44
pUP1 pHSS6 containing gonococcal uptake sequence (Kanr) 19
pEBH21 pBC II SK1 derivative (Cmr) 22
pUNCH319 pBluescript II SK1 containing 540-bp EcoRI-ClaI fragment from lfrpB.4 This study
pUNCH320 pBluescript II SK1 containing 5.3-kb ClaI-EcoRI fragment from lfrpB.4 This study
pUNCH321 pUP1 containing 540-bp EcoRI-ClaI fragment from pUNCH319 This study
pUNCH324 pUNCH321 containing V fragment from pHP45V in unique BglI site This study
pUNCH325 pBluescript II SK1 containing 2.8-kb ClaI-MluI fragment from pUNCH320 This study
pUNCH330 540-bp EcoRI-ClaI fragment from pUNCH319 in pACYC184 This study
pUNCH331 Reassembled gonococcal frpB gene in pACYC184 This study
l-ZapII Excisable lambda phage vector Stratagene
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atmosphere. Potassium cyanide was dissolved in 13 CDM. The vacuum manifold
was from the Millipore Multiscreen Assay System. Heme was used at 0.5 mM,
transferrin was used at 6.25 mM, and citrate was used at 100 mM. Membranes
were air dried overnight, and the Millipore punch kit was used to separate and
collect individual filters prior to counting. Data were expressed as counts per
minute per microgram of protein.
Preparation of aerobactin and enterobactin. Purified aerobactin and enter-
obactin were the generous gift of P. E. Klebba. Aerobactin was ferrated as
follows. Ferric sulfate was dissolved to 4 mM in 50 ml of distilled deionized H2O
containing 1.5 ml of HCl. Four hundred microliters of 4 mM aerobactin was
added to 400 ml of 4 mM ferric sulfate and 80 ml of 0.5 M Na2HPO4. The
ferri-aerobactin was run over a carboxymethyl-cellulose (Sigma) column equili-
brated in 0.05 M Na2HPO4. The final concentration of aerobactin was deter-
mined by reading the A400 (24).
Iron sources. Human Tf, human Lf, bovine heme, human hemoglobin, and
human haptoglobin were obtained from Sigma Chemical Co. 55Fe hemin was
purchased from the custom synthesizing facility at NEN Products Dupont (Wilm-
ington, Del.), lot no. FE55.1193RS. Tf, Lf, and citrate were ferrated with 55FeCl
as previously described (36).
RNase assay. The RNase assay was performed as previously described (71),
except that we used 0.1 N HCl instead of 0.5 N HCl.
Hemin affinity purification. Hemin agarose was purchased from Sigma Chem-
ical Co. The method of affinity purification was previously described by Lee (33).
Bactericidal assays. Bactericidal assays were performed as described previ-
ously (18).
Nucleotide sequence accession number. The gonococcal frpB sequence pre-
sented in this report was deposited with GenBank under the accession number
U13980.
RESULTS
Cloning the gonococcal frpB gene. Sarcosyl-insoluble mem-
brane fractions from gonococcal strain UU1008 were used to
obtain FrpB N-terminal amino acid sequence (see Materials
and Methods). A degenerate oligonucleotide containing in-
osine (designated MB.3, shown in Fig. 1) was deduced from
this sequence and used to probe a Southern blot of FA19
chromosomal DNA. Each restriction digest contained a single
hybridizing band (data not shown). A 5.8-kbDraI fragment was
chosen for further analysis.
A l-ZapII library containing EcoRI-linked FA19 chromo-
somal DraI fragments (2) was screened with oligonucleotide
MB.3. Approximately 1 positive plaque was identified for every
10,000 plaques screened. Attempts to excise the phagemid
containing the intact insert consistently resulted in deletion
products smaller than pBluescript II SK1 alone. Reasoning
that such a large chromosomal fragment potentially contained
both the frpB promoter and entire frpB coding sequence and
that the expression of FrpB might be toxic in E. coli, we
decided to subclone smaller fragments into pBluescript II SK1.
DNA prepared from one of the positively hybridizing
plaques, lfrpB-4 (Fig. 2), was digested with EcoRI to release
the insert DNA. The expected 5.8-kb fragment was isolated
from an agarose gel and further digested with ClaI to generate
a 540-bp, MB.3-hybridizing fragment and an approximately
5.3-kb fragment which did not hybridize to MB.3. The smaller
fragment ligated into pBluescript II SK1 was stable in E. coli
DH5aMCR and was designated pUNCH319. The larger frag-
ment ligated into pBluescript II SK1 generated pUNCH320.
pUNCH320 caused E. coli DH5aMCR to grow poorly and
appeared to be severely restricted in copy number. These data
suggested that other sequences located 39 of frpB may also be
toxic to E. coli and that further subcloning was necessary to
obtain stable clones. Digestion of pUNCH320 with MluI and
EcoRI released fragments of approximately 1.0 and 1.5 kb,
leaving a 2.8-kb ClaI-MluI fragment attached to pBluescript II
SK1. This 5.8-kb fragment (vector plus 2.8-kb ClaI-MluI in-
sert) was subsequently isolated, treated with Klenow fragment,
and religated to itself to generate pUNCH325. DH5aMCR
(pUNCH325) transformants were stable, and the plasmid copy
number was apparently normal.
Nucleotide sequence analysis of frpB. PCR amplification of
chromosomal DNA followed by sequence analysis of clones
confirmed the ClaI junction between pUNCH319 and
pUNCH325. The combined nucleotide sequence and deduced
amino acid sequence from pUNCH319 and pUNCH325 are
shown in Fig. 3. Putative promoter sequences were located
upstream of a well-conserved Fur box (4). A string of nine
cytosine residues was noted between the putative210 and235
RNA polymerase binding sites. A Shine-Dalgarno sequence
starting at nucleotide 307 and ending at nucleotide 310 (Fig. 3)
was located six bases before an ATG codon, the start of a
1,925-bp open reading frame (ORF). This ORF encoded a
protein of 713 amino acids. The predicted protein contained a
typical signal sequence and characteristic Ala-X-Ala, signal
peptidase I cleavage site. The first 10 amino acids adjacent to
the cleavage site were identical to the peptide sequence ob-
tained from the mature FrpB protein. A classical TonB box
was noted at residues 32 to 36. The mature protein had a
calculated molecular mass of 76.6 kDa and pI of 10.38. The
sequence downstream of the ORF revealed an inverted repeat
but no string of T residues characteristic of rho-independent
transcription termination (69). The protein terminated with an
aromatic residue preceded by nine alternating hydrophobic
and hydrophilic amino acids. This structure is typical of many
bacterial outer membrane proteins sequenced to date (58).
GenBank homologies. Comparison of FrpB with other se-
quences in GenBank revealed some interesting homologies.
Localized homology was found between FrpB and the family of
TonB-dependent outer membrane receptor proteins including
BtuB (25) and FepA (35) of E. coli and between Tbp1 (13) and
IroA (42) of Neisseria species. This similarity was limited to the
highly conserved domains (13) and suggested that FrpB may
FIG. 1. Amino acid sequence obtained for mature FrpB protein and oligo-
nucleotide MB.3. The FrpB amino acid sequence is shown above the frpB coding
sequence. Oligonucleotide MB.3 is shown 39 to 59 and corresponds to noncoding
strand.
FIG. 2. Restriction map of frpB clones. The position of the frpB ORF is
indicated below the physical map by the stippled box. Only relevant cloning sites
are shown: C, ClaI; D, DraI; E, EcoRI; M, MluI. Also shown is the position of
oligonucleotide MB.3, which was deduced from the amino-terminal amino acid
sequence of the mature protein.
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also be a TonB-dependent receptor. More similarity was found
with HemR, the hemin receptor of Yersinia enterocolitica (55).
HemR is an iron-regulated, outer membrane protein that is
also a member of the family of TonB-dependent receptor pro-
teins. Overall, the two proteins were 26% identical and 48%
similar. The most notable similarity was seen with CopB, a
major outer membrane protein ofMoraxella catarrhalis (26). A
physiological function for this protein has yet to be deter-
mined. Overall, FrpB and CopB were 52% identical and 71%
similar.
Transposon mutagenesis of frpB. In order to construct FrpB
mutants, the gonococcal insert in pUNCH319 was ligated into
pUP1 (19), creating pUNCH321. The V fragment from
pHP45V was ligated into a unique BglI site in pUNCH321
(insertion site shown in Fig. 3). This DNA was reintroduced
into the chromosome of gonococcal strain FA19 by transfor-
mation and allelic replacement, creating FA6807. Southern
blot analysis of chromosomal DNA from FA19 and FA6807
indicated that a 450-bp, MB.3-hybridizing HincII fragment
present in the parent was missing in FA6807 and a new reactive
band of approximately 2.5 kb was present (Fig. 4A). An iden-
tical blot (Fig. 4B) probed with V hybridized only to the 2.5-kb
fragment in FA6807. SDS-PAGE and Western blot analysis
with anti-FrpB monoclonal antibody W.6 confirmed that FrpB
was absent from this strain (Fig. 5).
The V insertion in frpB was also introduced into FA6747
[tbpA::mTn3(Cm)] by transformation and allelic replacement,
creating FA6808. The FrpB2 Tbp12 phenotype of FA6808 was
confirmed by SDS-PAGE and Western blot analysis (data not
shown). This strain was used for FrpB function analysis as
described below.
Utilization of iron sources. In an attempt to determine the
function that FrpB plays in iron utilization, FA19 and FA6807
were grown in CDM lacking iron. Aliquots of iron-stressed
cultures were plated onto CDM agarose containing 10 mM
Desferal and GC base agar containing 50 mMDesferal. Sterile
3-mm discs containing either citrate, Tf, Lf, heme, hemoglobin,
or hemoglobin bound to haptoglobin were positioned around
each plate. One disc without any added iron source was added
as a negative control. After overnight incubation, growth of
both strains was evident around all discs except the negative
control. These results did not suggest any obvious function for
FrpB in iron utilization.
Because it has been previously reported that N. gonorrhoeae
can utilize aerobactin (67) and enterobactin (45) as iron
sources, we decided to determine if FrpB functioned as either
an aerobactin or enterobactin receptor. FA19, FA6808,
FA6747, KDF541, KDF541/pABN6, and BN1071 (Table 1)
were iron stressed in CDM as described above and plated onto
CDM agarose containing 2.5 mM 30% iron-saturated Tf.
FA6747 and FA6808 could not use Tf as an iron source be-
cause they lacked Tbp1; therefore, these strains could grow
only in the presence of a functional high-affinity siderophore
FIG. 3. Nucleotide sequence of the gonococcal frpB gene. Single-letter codes
for deduced amino acid sequence are shown below the nucleotide sequence.
Asterisk indicates termination codon. Solid bar below nucleotide sequence in-
dicates putative Fur box. Putative 210 and 235 sequences are boxed. RBS
indicates ribosome binding site. Solid triangle shows BglI site of V insertion.
Vertical arrow indicates signal peptidase I cleavage site. Horizontal arrows in-
dicate inverted repeat.
FIG. 4. Southern blot analysis of FA19 and FA6807 DNA. Panel A was
probed with pUNCH319-specific fragment. Panel B was probed with the V
fragment. Lanes 1 contain FA19 DNA digested with HincII, and lanes 2 contain
FA6807 DNA digested with HincII. V fragment is 2 kb. Molecular size markers
are shown in kilobases.
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receptor. Three sterile discs were positioned around each
plate. Either 30% saturated Lf (positive control for gonococcal
viability) or filter-sterilized, iron-free supernatant from
LG1315 pColV (aerobactin producer) or AN102 (enterobactin
hyperproducer) was added to each disc. After overnight incu-
bation, E. coli controls grew as expected (data not shown),
suggesting that both siderophores were efficient at stripping
iron from Tf, the sole iron source provided in the medium.
FA19 grew over the entire Tf plate as expected; however,
growth of FA6808 and FA6747 was evident only around the Lf
discs, suggesting that the cells were viable but unable to use
aerobactin or enterobactin under these conditions.
We further examined the question of aerobactin utilization
by FA19 and FA6807 in liquid CDM, employing various con-
centrations of purified ferri-aerobactin (Fig. 6). Aerobactin
receptor-negative E. coli KDF541 and aerobactin receptor-
positive E. coli KDF541(pABN6) were used as controls (data
not shown). These data suggested that N. gonorrhoeae FA19
and FA6807 used ferri-aerobactin similarly and in a concen-
tration-dependent fashion analogous to the aerobactin recep-
tor-negative E. coli control. Growth stimulation of gonococci
by ferri-aerobactin required relatively high concentrations (3
mM) and never attained a density equivalent to that of the Tf
or citrate controls. These experiments confirmed the ability of
gonococci to utilize ferri-aerobactin as an iron source in vitro
but showed that this ability was not dependent upon a high-
affinity receptor-mediated event.
55Fe uptake from hemin, Tf, and citrate. Because of the high
degree of similarity between HemR, a known hemin receptor
in Y. enterocolitica, and FrpB, we decided to determine if a
quantitative difference in 55Fe uptake from hemin could be
detected between FA19 and FA6807. Uptakes of 55Fe from Tf
by FA19, FA6807, and the Tbp1 mutant FA6747 were used as
controls. The results indicated that while 55Fe uptake from Tf
was approximately wild type in FA6807 (P 5 0.826), 55Fe
uptake from hemin was reduced by approximately 60% (P ,
0.001) (Fig. 7). Surprisingly, 55Fe uptake from hemin was also
significantly reduced in FA6747 (P , 0.001). To determine
whether the inability to use 55Fe from hemin was specific to
FA6807 (FrpB2) and FA6747 (Tbp12), we assayed 55Fe up-
take from hemin in other well-characterized gonococcal mu-
tants specifically altered in the expression of other iron-re-
pressible proteins. The Tbp22 and Lbp2 strains, FA6819 and
FA6775, respectively, were also reduced in 55Fe internalization
from hemin (P , 0.001) (data not shown). These data sug-
gested that either more than one protein was involved in the
internalization of hemin iron or the notable decrease in hemin-
iron uptake in these mutants resulted from unanticipated, non-
specific effects of each of these mutations on a separate mem-
brane-bound, heme-iron-uptake system.
Reconstruction of frpB in pACYC184 and functional
complementation of RK1065 (hemA). In an attempt to deter-
FIG. 5. Western blot of FA19 and FA6807 membranes. Blot was probed with
anti-FrpB monoclonal antibody, W.6. Lanes 1 and 2 contain FA19; lanes 3 and
4 contain FA6807. Lanes 1 and 3 contain total membranes prepared from
iron-sufficient cultures; lanes 2 and 4 contain total membranes from iron-defi-
cient cultures. Approximate locations of molecular weight standards (MW) are
indicated at left in thousands.
FIG. 6. Growth of FA19 and FA6807 in CDM in the presence of variable concentrations of aerobactin. Graph A represents FA19; graph B represents FA6807. å,
100 mM citrate; ■, 2.5 mM Tf; Ç, 3 mM aerobactin; F, 1 mM aerobactin; h, 0.3 mM aerobactin; E, no iron source.
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mine if FrpB could function as a heme receptor, we tried to
complement an E. coli hemA mutant with FrpB. Although
expression of FrpB from the high-copy-number vector pBlue-
script II SK1 was toxic to E. coli, expression from the low-
copy-number vector pACYC184 was tolerated. The frpB re-
construction strategy is outlined in Fig. 8. Briefly, the insert
from pUNCH319 was ligated into the ClaI and BamHI sites of
pACYC184, generating pUNCH330. pUNCH330 was digested
with ClaI, and the gel-purified ClaI-XbaI fragment from
pUNCH325 was ligated into this site as follows. After ligating
for 4 h, Klenow fragment was added to the ligation mixture for
30 min at room temperature to repair nonligated ClaI and
XbaI ends. The reaction mixture was further ligated overnight.
The frpB clone in pACYC184 was designated pUNCH331.
FrpB expression from pUNCH331 was iron repressible, sug-
gesting regulation by E. coli Fur (data not shown).
RK1065 is an E. coli hemA mutant which is unable to syn-
thesize or internalize heme (27). Growth stimulation requires
either d-aminolevulinic acid or heme and a functional heme
receptor. Transformation of pUNCH331 into RK1065 sup-
ported growth on heme plates, whereas pACYC184 alone did
not (Fig. 9). We performed an RNase leakage assay, to deter-
mine if FrpB expression altered the E. coli outer membrane,
thereby allowing heme to simply diffuse into the cell (71).
E. coli C386 and HB101 containing pEBH21 were used as
positive and negative controls, respectively. No difference in
leakiness was detected between RK1065(pACYC184) and
RK1065(pUNCH331) (data not shown), suggesting that
growth of RK1065(pUNCH331) on heme plates was not due to
a membrane perturbation gross enough to permit leakage of
the periplasmic protein RNase H. Nevertheless, RK1065
(pUNCH331) was more sensitive to several hydrophobic anti-
biotics than the same strain with pACYC184 alone (Fig. 9).
This experiment suggested that the presence of FrpB in E. coli
probably allowed heme to enter nonspecifically either by cre-
ating a pore or by perturbing the integrity of the outer mem-
brane. No KCN-inhibitable uptake of 55Fe from hemin could
be attributed to expression of FrpB in RK1065(pUNCH331)
(data not shown).
Bactericidal assay. In M. catarrhalis, CopB, the protein with
the greatest similarity to FrpB, appears to play a major role in
serum resistance. Mutants which are missing CopB have de-
creased serum resistance and survival in a mouse model (26).
We performed standard bactericidal assays with normal human
serum on FA19 and FA6807 grown under iron-limiting condi-
tions and were unable to detect any difference in survival; both
strains were completely serum resistant (data not shown).
FIG. 7. 55Fe uptake from 55Fe-heme and 55Fe-Tf. Solid columns represent
mean uptake from heme, and open columns represent mean uptake from Tf.
One hundred percent uptake was determined from average FA19 uptake exper-
iment. Standard deviations are indicated by error bars. The strains and genotypes
are FA19 (wild type), FA6807 (frpB), and FA6747 (tpbA).
FIG. 8. Reconstruction of frpB in pACYC184. Relevant sites are BamHI (B),
ClaI (C), DraI (D), MluI (M), and XbaI (X). Solid arrow represents chloram-
phenicol acetyltransferase (Cm), striped arrow represents tetracycline resistance
gene (Tc), solid bar represents pACYC184 origin of replication (ORI), stippled
boxes represent frpB coding sequences, stippled arrow indicates entire frpB
coding regions, and open boxes represent DNA 59 and 39 of frpB. frpB9 and frpB0
represent partial frpB coding sequences.
FIG. 9. Growth of RK1065(pACYC184) and RK1065(pUNCH331) on heme
plates. Plate 1 contains heme only. Plate 2 contains heme and d-aminolevulinic
acid. A is RK1065(pACYC184) and B is RK1065(pUNCH331). Antibiotic discs
are erythromycin (E), novobiocin (N), and rifampin (R).
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DISCUSSION
FrpB is a major iron-regulated, outer membrane protein in
many gonococcal and meningococcal strains. Its surface expo-
sure (1, 16, 41), partial antigenic conservation (8, 16), and
susceptibility to attack by bactericidal antibodies (41) warrant
its study as a potential vaccine candidate. We have cloned and
sequenced frpB from gonococcal strain FA19 and studied its
possible role in iron uptake. Several regions of the predicted
FrpB protein shared similarity with regions identified in other
proteins as potentially important for membrane localization
and/or TonB interaction. TonB in association with ExbB and
ExbD is believed to transduce the energy from the proton
motive force generated in the cytoplasmic membrane to recep-
tors in the outer membrane (43). FrpB also shared a significant
region of similarity with a 104-amino-acid domain of HemR,
the heme receptor of Y. enterocolitica. While this region in-
cluded one of the highly conserved TonB domains (13), it also
extended a significant distance upstream and downstream of
this region. These homologies suggested that FrpB may be a
TonB-dependent receptor.
In order to assess the function of FrpB in iron utilization, we
constructed an insertional mutant of the cloned gene in E. coli
and introduced it by transformation and allelic replacement
into the chromosome of FA19. This mutant, FA6807, was able
to grow in the presence of all tested iron sources including Tf,
Lf, citrate, heme, hemoglobin, and hemoglobin bound to hap-
toglobin. 55Fe uptake from Lf (data not shown), Tf, and citrate
by FA6807 was similar to that by wild type, while 55Fe uptake
from hemin was approximately 60% reduced. These data
opened the possibility that FrpB was involved in heme iron
uptake. However, other gonococcal mutants missing either
Tbp1, Tbp2, or Lbp were also reduced in 55Fe from heme.
Thus, the heme uptake-deficient phenotype was not specific to
FrpB. It is possible that Tbp1, Tbp2, and Lbp form an outer
membrane protein complex which is essential to the configu-
ration of proteins involved in heme-iron uptake. Inactivation
of one member of this complex may alter nearby proteins, thus
affecting the cell’s ability to utilize heme-bound iron. We did
not investigate the possible effects of FrpB, Tbp1, Tbp2, or Lbp
mutants on the surface accessibility of other iron-repressible
proteins such as those isolated by hemin-affinity purification.
The ability of the pathogenic Neisseria spp. to acquire iron
from heme, hemoglobin, and hemoglobin bound to haptoglo-
bin has been well documented (3, 17, 38). However, the mech-
anism(s) of iron uptake from these sources has never been
defined. Recently, Lee (33) isolated two iron-repressible gono-
coccal proteins of 97 and 44 kDa by hemin-affinity chromatog-
raphy. The function of these proteins in iron uptake from heme
was not addressed. We used the hemin-affinity purification
procedure employed by Lee (33) to isolate hemin-binding pro-
teins from FA19. While we were able to isolate a protein of
approximately 97 kDa and several smaller-molecular-mass
proteins, we were unable to purify FrpB by this procedure
(data not shown).
The homology between FrpB and HemR of Y. enterocolitica
prompted experiments to determine if FrpB could comple-
ment an E. coli mutant deficient in heme synthesis. Stojiljkovic
and Hantke (55) originally reported that two gene products,
HemR and HemP, from Y. enterocolitica were required to
complement an E. coli hemAmutant, but recently, it was shown
that just HemR expressed on a low-copy-number plasmid was
sufficient (56). FrpB expressed on a low-copy-number vector
also allowed RK1065hemA to grow on heme plates as the sole
source of porphyrin. However, expression of FrpB in RK1065
increased the susceptibility of this strain to hydrophobic anti-
biotics that are normally impermeable to the E. coli outer
membrane, suggesting that the heme utilization phenotype
could result from the creation of a nonspecific pore or other
alteration in the outer membrane generated by the presence of
FrpB.
Fur is a 17-kDa protein that in the presence of iron binds to
the Fur box in the promoter region of iron-regulated genes and
represses transcription (4). Both gonococcal (5) and meningo-
coccal (59) Fur homologs have been characterized. An in-
verted repeat located just upstream of the frpB coding se-
quence matched the E. coli consensus Fur box in 13 of 19
bases, including 100% identity with the seven highly conserved
bases (4) of the E. coli Fur box. Expression of FrpB by N.
gonorrhoeae and E. coli was iron regulated, and it is likely that
this regulation was mediated by Fur.
Expression of FrpB in vitro can vary significantly between
different gonococcal strains (data not shown). We have also
observed considerable variability of FrpB expression during in
vitro passage of single gonococcal strains (data not shown). A
string of cytosine residues located between the putative 210
and235 promoter elements of frpBmay be responsible for this
alteration. Slipped-strand mispairing is known to occur readily
at repeated sequence elements (34, 57), and loss or gain of a
single base pair in a promoter region may alter the affinity of
RNA polymerase for a promoter. In Mycoplasma hyorhinis,
changes in the number of adenine residues between 210 and
235 elements are believed to regulate the variable expression
of a set of surface-exposed lipoproteins (vlp) (70). In Bordetella
pertussis, alterations in the number of cytosines in the pro-
moter region of the fimbrial genes (fim) are implicated in
phase variation (68). In Haemophilus influenzae, a string of TA
repeats in the overlapping promoter region of the fimbrial
subunit (hifA) and a fimbrial chaperone protein (hifB) medi-
ates the phase variation of these proteins (62). Recently, vari-
ation in expression of the Opc protein of N. meningitidis was
shown to be due to changes in the number of cytosines in the
promoter element of this gene (49). Additional studies are
required to determine if alteration in the cytosine tract pre-
ceding frpB results in changes in expression levels of FrpB and
to understand the physiological role of FrpB in the biology of
gonococcal infection.
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